Cano Health (CANO) April (2023) 7 and January (2024) 10 call spreaders active

Go back to Cano Health (CANO) April (2023) 7 and January (2024) 10 call spreaders active

Citi Reiterates $7 PT on Cano Health (CANO), Says Takeout Could Be Worth $14 on Roughly 2x Revenue

September 23, 2022 12:18 PM EDT

Citi analyst Jason Cassorla reiterated a Buy rating and $7.00 price target on Cano Health (NYSE: CANO).

The analyst comments "Another Takeout Headline Not Surprising: Multiple headlines over the past ~six months have suggested CANO could potentially be acquired. To this end, CANO traded at ~1.0x our 2023E revenue at an unaffected price of $6.31 (September 21st close), which compares to its SPAC merger multiple at ~3x forward revenue, and other recent deals in the space including AMZNs... More

CVS Health (CVS) Said to Consider Potential Bid for Cano Health (CANO) - Bloomberg

September 22, 2022 3:28 PM EDT

CVS Health (NYSE: CVS) Said to Consider Potential Bid for Cano Health (NYSE: CANO) - Bloomberg

... More

Cano Health (CANO) Said to Weigh Sale - Bloomberg

September 22, 2022 3:24 PM EDT

Cano Health (NYSE: CANO) Said to Weigh Sale - Bloomberg

Appears to confirm WSJ story moments ago
... More